[1]
Foley, R., Owen, C., Tabchi, S. and Razavi, G. 2022. Panel Discussion: Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients. Canadian Hematology Today. 1, S10 (Oct. 2022). DOI:https://doi.org/10.58931/cht.2022.1S1029.